Regression of copper-deficient heart hypertrophy: reduction in the size of hypertrophic cardiomyocytes

Journal of Nutritional Biochemistry

Volumn 20, Issue 8, 2009, Pages 621-628

  Zhou, Zhanxiang ^a   Johnson, W Thomas ^a   Kang, Y James ^a,b  

^a University of Louisville School of Medicine   (United States)

^b GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Cell cycle; Copper; Hypertrophy; Mitosis; Myocardial regeneration; Regression

Indexed keywords

ALPHA ACTIN; COPPER; HISTONE H3; KI 67 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL CYCLE; CELL DIVISION; CELL SIZE; CONTROLLED STUDY; COPPER DEFICIENCY; HEART HYPERTROPHY; HEART MUSCLE CELL; MITOSIS; MOUSE; MOUSE STRAIN; NONHUMAN; QUANTITATIVE ANALYSIS; REMISSION; TISSUE REGENERATION;

ANIMALS; CARDIOMEGALY; CELL COUNT; CELL CYCLE; CELL SIZE; COPPER; DISEASE MODELS, ANIMAL; FEMALE; FOOD, FORMULATED; HEART; MALE; MICE; MITOCHONDRIA, HEART; MITOSIS; MYOCARDIUM; MYOCYTES, CARDIAC; NUTRITIONAL STATUS; REGENERATION;

MUS;

EID: 67649683001     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2008.06.007     Document Type: Article

References (27)

1. Medeiros D.M., and Wildman R.E. Newer findings on a unified perspective of copper restriction and cardiomyopathy. Proc Soc Exp Biol Med 215 (1997) 299-313
2. Elsherif L., Ortines R.V., Saari J.T., and Kang Y.J. Congestive heart failure in copper-deficient mice. Exp Biol Med 228 (2003) 811-817
3. Elsherif L., Wang L., Saari J.T., and Kang Y.J. Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice. J Nutr 134 (2004) 855-860
4. Sabbah H.N., and Sharov V.G. Apoptosis in heart failure. Prog Cardiovasc Dis 40 (1998) 549-562
5. Kang Y.J., Zhou Z.X., Wu H., Wang G.W., Saari J.T., and Klein J.B. Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide. Lab Invest 80 (2000) 745-757
6. Richey P.A., and Brown S.P. Pathological versus physiological left ventricular hypertrophy: a review. J Sports Sci 16 (1998) 129-141
7. Kishimoto I., Rossi K., and Garbers D.L. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci U S A 98 (2001) 2703-2706
8. Zahabi A., Picard S., Fortin N., Reudelhuber T.L., and Deschepper C.F. Expression of constitutively active guanylate cyclase in cardiomyocytes inhibits the hypertrophic effects of isoproterenol and aortic constriction on mouse hearts. J Biol Chem 278 (2003) 47694-47699
9. Boluyt M.O., O'Neill L., Meredith A.L., Bing O.H., Brooks W.W., Conrad C.H., et al. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components. Circ Res 75 (1994) 23-32
10. Flesch M., Erdmann E., and Bohm M. Changes in beta-adrenoceptors and G-proteins during the transition from cardiac hypertrophy to heart failure. J Card Fail 2 (1996) S35-S43
11. Grossman W. Diastolic dysfunction in congestive heart failure. N Engl J Med 325 (1991) 1557-1564
12. Chemla D., Coirault C., Hebert J.L., and Lecarpentier Y. Mechanics of relaxation of the human heart. News Physiol Sci 15 (2000) 78-83
13. Reeves P.G., Nielsen F.H., and Fahey Jr. G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet. J Nutr 123 (1993) 1939-1951
14. Kang Y.J., Chen Y., Yu A., Voss-McCowan M., and Epstein P.N. Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J Clin Invest 100 (1997) 1501-1506
15. Scholzen TGerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 182 (2000) 311-322
16. Wei Y., Yu L., Bowen J., Gorovsky M.A., and Allis C.D. Phosphorylation of histone H3 is required for proper chromosome condensation and segregation. Cell 97 (1999) 99-109
17. Zhou Y., Jiang Y., and Kang Y.J. Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size. J Mol Cell Cardiol 45 (2008) 106-117
18. Jiang Y., Reynolds C., Xiao C., Feng W., Zhou Z., Rodriguez W., et al. Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. J Exp Med 204 (2007) 657-666
19. Zafeiridis A., Jeevanandam V., Houser S.R., and Margulies K.B. Regression of cellular hypertrophy after left ventricular assist device support. Circulation 98 (1998) 656-662
20. Mancini D.M., Beniaminovitz A., Levin H., Catanese K., Flannery M., DiTullio M., et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 98 (1998) 2383-2389
21. Muller J., Wallukat G., Weng Y.G., Dandel M., Spiegelsberger S., Semrau S., et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 96 (1997) 542-549
22. Zama N., and Towns R.L.R. Cardiac copper, magnesium, and zinc in recent and old myocardial infarction. Biol Trace Elem Res 10 (1986) 201-208
23. Wester P.O. Trace elements in human myocardial infarction determined by neutron activation analysis. Acta Med Scand 178 (1965) 765-788
24. Chipperfield B., and Chipperfield J.R. Differences in metal content of the heart muscle in death from ischemic heart disease. Am Heart J 95 (1978) 732-737
25. Anderson T.W., Neri L.C., Schreiber G.B., Talbot F.D., and Zdrojewski A. Letter: ischemic heart disease, water hardness and myocardial magnesium. Can Med Assoc J 113 (1975) 199-203
26. Klevay L.M., and Saari J.T. Comparative responses of rats to different copper intakes and modes of supplementation. Proc Soc Exp Biol Med 203 (1993) 214-220
27. Schaub M.C., Hefti M.A., Harder B.A., and Eppenberger H.M. Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes. J Mol Med 75 (1997) 901-920